Literature DB >> 19397592

Effects of core binding factor alpha1 or bone morphogenic protein-2 overexpression on osteoblast/cementoblast-related gene expressions in NIH3T3 mouse cells and dental follicle cells.

K Pan1, S Yan, S Ge, S Li, Y Zhao, P Yang.   

Abstract

OBJECTIVES: Bone morphogenic protein-2 (BMP-2) has long been used to promote bone and periodontal regeneration, while core binding factor alpha1 (CBFA1) plays important roles in both osteogenic differentiation and tooth morphogenesis. The aim of this study was to evaluate the effects of CBFA1 or BMP-2 overexpression on osteoblast/cementoblast-related gene expressions in NIH3T3 cells and dental follicle cells (DFCs).
MATERIALS AND METHODS: CBFA1 or BMP-2 overexpression in NIH3T3 and DFCs was achieved by infection with retroviral vectors containing CBFA1 or BMP-2 cDNA. Cells stably integrated with CBFA1 or BMP-2 cDNA were selected with G418 for 14 days. Western blotting, real-time reverse transcriptase-polymerase chain reaction, and in vitro mineralization assay were performed to evaluate effects of CBFA1 or BMP-2 overexpression in cells undergoing osteoblast/cementoblast differentiation.
RESULTS: Our results demonstrated that osteoblast/cementoblast-related gene expression levels in CBFA1-overexpressing NIH3T3 cells were higher than those in BMP-2-overexpressing cells. More mineral nodules were observed in CBFA1-overexpressing NIH3T3 cells than in BMP-2-overexpressing cells. CBFA1 overexpression in DFCs also increased osteoblast/cementoblast-related gene expression and promoted mineral nodule formation. However, no significant changes in gene expression levels nor mineral nodule formation were found in BMP-2-overexpressing DFCs when compared with empty vector transduced DFCs.
CONCLUSIONS: CBFA1 overexpression up-regulated expression levels of osteoblast/cementoblast-related genes and enhanced in vitro osteogenic differentiation more efficiently than BMP-2 in both NIH3T3 cells and DFCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19397592      PMCID: PMC6496175          DOI: 10.1111/j.1365-2184.2009.00599.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  49 in total

Review 1.  Bone morphogenetic proteins: from basic science to clinical applications.

Authors:  A H Reddi
Journal:  J Bone Joint Surg Am       Date:  2001       Impact factor: 5.284

Review 2.  The impact of gene therapy on dentistry: a revisiting after six years.

Authors:  Bruce J Baum; Marc Kok; Simon D Tran; Seiichi Yamano
Journal:  J Am Dent Assoc       Date:  2002-01       Impact factor: 3.634

Review 3.  On the repair potential of periodontal tissues.

Authors:  A H Melcher
Journal:  J Periodontol       Date:  1976-05       Impact factor: 6.993

4.  Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

Authors:  P Ducy; R Zhang; V Geoffroy; A L Ridall; G Karsenty
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.

Authors:  Shunmugam Govender; Cristina Csimma; Harry K Genant; Alexandre Valentin-Opran; Yehuda Amit; Ron Arbel; Hannu Aro; Dan Atar; Michael Bishay; Martin G Börner; Philippe Chiron; Peter Choong; John Cinats; Brett Courtenay; Robert Feibel; Bernard Geulette; Charles Gravel; Norbert Haas; M Raschke; Eric Hammacher; D van der Velde; Philippe Hardy; Michael Holt; Christof Josten; Rupert Ludwig Ketterl; Bennie Lindeque; Günter Lob; Henry Mathevon; Gerald McCoy; D Marsh; Russell Miller; Everard Munting; Stein Oevre; L Nordsletten; Amratlal Patel; Anthony Pohl; William Rennie; Peter Reynders; Pol Maria Rommens; Jean Rondia; Willem C Rossouw; P J Daneel; Stephen Ruff; Axel Rüter; Seppo Santavirta; Thomas A Schildhauer; C Gekle; Reinhard Schnettler; David Segal; Hanns Seiler; Robert B Snowdowne; Jouwert Stapert; Gilbert Taglang; Rene Verdonk; Lucas Vogels; Arnulf Weckbach; Andreas Wentzensen; Tadeusz Wisniewski
Journal:  J Bone Joint Surg Am       Date:  2002-12       Impact factor: 5.284

6.  Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2. A pilot study in Chacma baboons (Papio ursinus).

Authors:  U Ripamonti; J Crooks; J C Petit; D C Rueger
Journal:  Eur J Oral Sci       Date:  2001-08       Impact factor: 2.612

7.  Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs.

Authors:  Seong-Ho Choi; Chong-Kwan Kim; Kyoo-Sung Cho; Ji-Sun Huh; Rachel G Sorensen; John M Wozney; Ulf M E Wikesjö
Journal:  J Periodontol       Date:  2002-01       Impact factor: 6.993

Review 8.  Bone morphogenetic proteins.

Authors:  Di Chen; Ming Zhao; Gregory R Mundy
Journal:  Growth Factors       Date:  2004-12       Impact factor: 2.511

9.  Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery.

Authors:  Q Kang; M H Sun; H Cheng; Y Peng; A G Montag; A T Deyrup; W Jiang; H H Luu; J Luo; J P Szatkowski; P Vanichakarn; J Y Park; Y Li; R C Haydon; T-C He
Journal:  Gene Ther       Date:  2004-09       Impact factor: 5.250

Review 10.  A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft).

Authors:  William F McKay; Steven M Peckham; Jeffrey M Badura
Journal:  Int Orthop       Date:  2007-07-17       Impact factor: 3.075

View more
  4 in total

1.  Multilineage differentiation of dental follicle cells and the roles of Runx2 over-expression in enhancing osteoblast/cementoblast-related gene expression in dental follicle cells.

Authors:  K Pan; Q Sun; J Zhang; S Ge; S Li; Y Zhao; P Yang
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

2.  Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.

Authors:  Nagat Frara; Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Vanessa R Yingling; Thomas A Owen; Steven N Popoff; Mary F Barbe; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2016-01       Impact factor: 6.384

3.  Regulatory effects of bone morphogenetic protein-4 on tumour necrosis factor-α-suppressed Runx2 and osteoprotegerin expression in cementoblasts.

Authors:  Yunlong Wang; Hong He; Zhengguo Cao; Yi Fang; Mingyuan Du; Zhijian Liu
Journal:  Cell Prolif       Date:  2017-02-28       Impact factor: 6.831

4.  Effects of Panax notoginseng saponins on proliferation and differentiation in NIH3T3 cells.

Authors:  Li-Ming Yin; Xiao Wang; Xu-Dai Qian; Xiao-Jie Lin; Xiao-Hong Chen; Rui-Lan Gao
Journal:  Chin J Integr Med       Date:  2012-08-02       Impact factor: 1.978

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.